Physician profile
Anna J Ross
NPI 1578594354
$4,710.78
in general payments reported to CMS, 2019-2025
18 companies · $1,448 in 2025
The $1,448 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $63.16 · 2021: $157 · 2022: $565 · 2023: $595 · 2024: $1,574 · 2025: $1,448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,616.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,014.79 | 2022-2025 | |
| Alcon Vision LLC | $902.83 | 2022-2025 | Rocklatan, Clareon Panoptix Pro, Tryptyr |
| Dompe US, INC. | $504.97 | 2024-2025 | Oxervate |
| Bausch & Lomb Americas INC. | $415.62 | 2022-2025 | Miebo, Vyzulta, Xiidra |
| Oyster Point Pharma, INC. | $388.25 | 2022-2025 | Tyrvaya, Ryzumvi |
| Sun Pharmaceutical Industries INC. | $308.81 | 2019-2025 | |
| Harrow Eye, LLC | $273.77 | 2024-2025 | Vevye |
| Tarsus Pharmaceuticals, INC. | $189.84 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $170.83 | 2019-2021 | |
| Allergan, INC. | $125.15 | 2022 | |
| Abbvie INC. | $100.24 | 2022-2024 | |
| Shire North American Group INC | $89.80 | 2019 | |
| Eyevance Pharmaceuticals LLC | $65.53 | 2022-2023 | Flarex |
| Aerie Pharmaceuticals, INC. | $52.83 | 2019-2021 | |
| Thea Pharma INC. | $43.69 | 2023-2025 | Iyuzeh |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $23.02 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.41 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.